[Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety].

CONCLUSION: Using Ologen as drug depot for bevacizumab in a trabeculectomy (TE) with MMC is a safe and active surgical method without an increased risk of complications in comparison to pure TE with MMC or TE with MMC and Ologen implant. After 12 months, this treatment exhibited no significant advantages.
PMID: 30736077 [PubMed - as supplied by publisher]

Source: Klinische Monatsblatter fur Augenheilkunde - February 9, 2019 Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research